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 Macrophages play a key role in both the innate and adaptive immune system 
responses to foreign materials. Suppressors of cytokine signaling (SOCS) proteins are 
known as regulators of the immune response through various JAK/STAT pathways. This 
study examined the roles of SOCS1 and SOCS3 peptide mimetics on the phagocytosis of 
fluorescently labeled malignant target cell by RAW264.7 murine macrophages. The 
malignant cells used were Neuro-2a cells, a murine neuroblastoma cell line. A prominent 
“eat me” signal found in neuroblastoma cells is calreticulin (CRT), which permits 
macrophages to recognize and then phagocytize the malignant cells. When M1 (pro-
inflammatory) polarized macrophages were treated with a SOCS1 peptide mimetic, an 
increase in phagocytosis was observed, but a SOCS3 peptide mimetic had no effect on 
phagocytosis. Neither SOCS1 nor 3 peptide mimetics showed a significant effect on the 
phagocytosis ability of the M2 (anti-inflammatory) polarized macrophages when target 
cells were stained with carboxyfluorescein succinimidyl ester (CFSE). When target cells 
were treated with anti-CRT, phagocytosis was decreased by both M1 and M2 polarized 
macrophages. When M2 macrophages were treated with SOCS3 peptide mimetic and 
target cells were blocked with anti-CRT, which initiates apoptosis, an increase in 
phagocytosis compared to unblocked target cells was observed. These results contribute 
iv	
to our continuing understating of the primary functions of M2 macrophages in wound 
healing and clearance of apoptotic cells. Overall this study provides a mechanism by 
which SOCS1/3 peptide mimetics can enhance phenotypic specific phagocytosis of pro-
inflammatory M1 macrophages and anti-inflammatory M2 macrophages. 
v	
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 Neuroblastoma (NB) is a form of childhood cancer that affects thousands of 
children every year. This form of malignancy is typically diagnosed in the early years of 
the child’s life and has the highest mortality rate of any adolescent cancer (Cheung and 
Dyer, 2013). This form of childhood cancer progresses in the early stages of embryonic 
development. The malignant cells form from the neural crest and are most often found 
along the nervous system once they are detected (Heck et al, 2009). Very rarely do NB 
tumors form in a hereditary manner; most cases that are studied are spontaneous 
mutations and these mutations have low incidence of occurring in the same gene. The 
most frequent gene that is mutated in both hereditary and spontaneous cases is the ALK 
gene (Pugh et al., 2009). NB’s have very efficient mechanisms, which they use to evade 
the immune system; these mechanisms include manipulation of both the innate and 
adaptive immune system. 
Some methods used by NB’s include the down regulation of cell surface markers 
that normally allow recognition by host T cells. They are also capable of recruiting 
macrophages to alter host immune cells to promote their own survival (Cheung and Dyer, 
2013). Other cell types that play a vital role in the survival of tumors are natural killer 
cells, tumor-associated macrophages, dendritic cells, and myeloid suppressor cells. All of 
these cell types play different roles in the tumor cell environment including cytokine 
production, activation signaling and tumor phenotype editing that will promote an 
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environment for tumor survival (Whiteside, 2008). One cellular signal in particular has 
been at the forefront of research into the prognoses of tumor states and also looked at for 
new potential treatment options for various stages of tumor progressions. The signal of 
interest is calriticulin (CRT), found in five different types of cancers, acts as an “eat me” 
signal. “Eat me” signals are a signal that phagocytes, or macrophages, will recognize 
through specific cell surface receptors; this recognition allows the phagocytes to 
efficiently clear the cells from the cellular environment (Chao et al., 2012). However, 
tumor cells have the ability to promote their own survival by up regulating the expression 
of cluster of differentiation (CD) 47, a “don’t eat me” signal that works to offset the 
amount of CRT expression so it can survive (Chao et al., 2010).  
 Clearance of foreign materials, including tumors, from the cellular environment 
involves a multitude of signals to work in conjunction with one another. These signals 
include but are not limited to CRT, CD47, and phosphatidylserine (PS). Living cells tend 
to express both CRT and CD47, with CD47 having a greater expression to silence the 
“eat me” signal from CRT (Raghavan et al., 2013). Conversely it has been shown that 
CRT has had higher levels of expression in patients that had neuroblastomas and survived 
(Hsu et al., 2004). Cells that begin to undergo the early stages of apoptosis will express 
PS a signal that is universally recognized by phagocytes that are in the surrounding 
cellular microenvironment (Segawa and Nagata, 2015). Under normal circumstances PS 
is not overtly expressed on the cell surface and CRT will be expressed on malignancies. 
The expression of PS will be increased when the cell becomes stressed from an outside 
stimulant. If one of these signals is blocked or altered the opposing signal will then be 
expressed at a much higher ratio making it more easily recognizable by phagocytes 
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(Krysko and Vandenabeele, 2008). The manipulation of these signals present on tumor 
cells in a manner that promotes the clearance of tumors is at the forefront of cancer 
biology research.  
Macrophages are considered to be one of the most important and dependable cell 
types in the immune system. Macrophages are relied on because they are able to tie in 
both the innate and adaptive immune systems. The prominent role they play in innate 
immunity consists of clearing cellular debris while also protecting the immune system 
from uncommon material such as, pathogens, bacterial infections, or tumors (Mosser and 
Edwards, 2008). The phagocytosis of these foreign materials will lead the macrophages 
to undergo various changes to their cellular morphology and physiology, which include 
the production of various cytokines, transduction of signals to help clear the material, and 
a change in cellular shape (Murray and Wynn, 2011). The production of innate immunity 
cytokines help recruit adaptive immune cells, these adaptive immune cells include T and 
B cells. Macrophages also have a role in the development of many inflammation diseases 
and autoimmune disorders.  
The various roles macrophages play in the immune system include protecting the 
host from various contaminants, regulating immune responses, and assisting in the 
healing after a traumatic event. When conducting these functions of the immune system 
macrophages can generally be classified into two different categories: M1 or M2 
macrophages (Qian and Pollard, 2010). Both types of macrophages are stimulated or 
polarized by different molecules that lead to their altered roles in the immune system. 
Typically these two distinctively different macrophages act in contradictory roles but will 
act together to protect the host. For example, M1 macrophages conduct their responses in 
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a pro-inflammatory pattern as where M2 macrophages will have an anti-inflammatory 
response to an immune challenge (Murray and Wynn 2011). Another hallmark difference 
between the two macrophage phenotypes is their difference in cellular shape when 
stimulated with phenotype specific cytokines. M1 macrophages will typically be round 
and appear flattened in shape with the appearance of vacuoles inside the cell. The M2 
macrophages appear to be elongated in shaped without any vacuoles present (McWhorter 
et al., 2013). 
One of macrophages main contributions to an innate immune response is the 
engulfment of particles and for this reason they are referred to as a professional 
phagocyte (Flanngan et al., 2012). Phagocytosis is a widely studied cellular process but 
because it involves so many different components and molecules a true understanding of 
the exact mechanisms involved has yet to be mutually agreed upon. There is a massive 
overlap of signals and receptors in phagocytosis, that are also involved in many other 
cellular functions this shows the importance of the process in relation to stabilization of 
the cellular microenvironment (Stuart and Ezekowitz, 2008). Toll-like receptors (TLRs) 
and pattern recognition receptors (PRRs) are two of the key components that have a 
multifaceted role in overall function. Both of there receptors, when bound by a pathogen 
or foreign material, trigger a downstream cascade that leads to the expression of 



























Suppressors of cytokine signaling (SOCS) proteins are a family of proteins that 
assist in the regulation of cytokines and therefore affect the development and 
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differentiation of multiple cell types including macrophages. SOCS proteins are both 
stimulated by cytokines and regulate cytokine production; therefore, they act on target 
cells in a negative-feedback loop (Yoshimura et al., 2007). SOCS proteins are capable of 
regulating the production of various cytokines by binding of the kinase inhibitory region 
(KIR) of the SOCS protein to Janus kinase/ signal transducers and activators of 
transcription, or more commonly know as JAK/STAT pathway. In this pathway the 
specific cytokines will bind their receptors, this binding of cytokine will then activate a 
cytokine specific JAK kinase and the substrates of the activated JAK kinases are the 
various STAT proteins. SOCS proteins disrupt this pathway by blocking the STAT 
protein from interacting with the activated JAK kinases (Tamiya et al., 2011). Two of the 
most important SOCS proteins are SOCS1 and SOCS3; these two proteins are thought to 
play an extremely important role in inflammatory diseases and tumor development 
(Whyte et al., 2011 and Carow and Rottenberg, 2014). Both of these proteins, SOCS1/3 
have the ability to interact directly with JAK through their KIR. SOCS proteins play a 
very dynamic role in cellular function. The ratio of SOCS1 to SOCS3 proteins will 
determine the inflammatory state of macrophages in response to an immunological 
challenge (Yoshimura et al., 2012). The current progress on SOCS protein interactions 
with the JAK/STAT pathway is leading to more studies involving different disease 
models. Progress in this field is contributing to a more well rounding understanding on 
the importance that the cellular microenvironment has on disease progression. Hopefully 
leading to a mechanism that explains a method to increase the clearance and removal of 
malignancies.  
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SOCS1 is most often associated with the inhibition of IFN-γ signaling, by acting 
as an alternative substrate to an activated JAK, blocking the ability of the STAT protein 
associated with IFN-γ signaling. SOCS1 is a key regulator in activation and maintenance 
of both M1 and M2 polarized macrophages. The ratio of SOCS1 to SOCS3 is at higher 
levels in M2 polarized macrophages and the ratio of SOCS3 to SOCS1 is higher in M1 
macrophages (Whyte et al., 2011). The role of SOCS1 has been studied most often 
through mice that have the SOCS1 gene deleted. These mice typically die within the first 
month from having constitutively active IFN signaling pathways. Leading to an increased 
activation of T cells and macrophages attacking various organs in an autoimmune disease 
manner (Kubo and Yoshimura, 2003). Other inflammatory cytokines and pathways that 
are affected in knockout mice are TNF, IL-12, nitric oxide, NF-kB and TLR signaling 
(Yoshimura et al., 2007). 
In terms of their mechanism of action SOCS3 acts in a very similar manner to 
SOCS1, the only difference is that different cytokine receptors area involved. SOCS3 
typically acts as a negative inhibitor of cytokines, these cytokines include IL-6, IL-10, 
and IL-2. In many mouse models SOCS3 has been shown to play an important role in 
effecting inflammation and immune responses (Carow and Rottenberg, 2014). Current 
studies examining the affects of SOCS3 on the immune response involve a complete 
knockout of the SOCS3 gene. Upon knockout of the SOCS3 gene a greater amount of pro 
inflammatory cytokines was observed. Also, the deletion of SOCS3 enhances the amount 
of phagocytosis of M1 polarized macrophages (Qin et al., 2012). Showin the importance 
of SOCS3 as an immune system regulator of phagocytosis in a murine model.  
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The current study focuses on the role that SOCS peptide mimetics have on the 
inflammatory properties of RAW264.7 murine macrophages. The main inflammatory 
property associated with murine macrophages is the process of phagocytosis, carried out 
by both M1 and M2c polarized macrophages. SOCS peptide mimetics can alter the 
percentage of target cells being cleared by inhibiting the production of certain cytokines 
and by increasing receptor expression. Based on current literature I hypothesize that the 
treatment of anti-inflammatory M2 macrophages with SOCS1 peptide mimetic will 
exhibit a pro-inflammatory property of increased phagocytosis of target cells. Similarly, 
SOCS3 peptide mimetic will decrease the inflammatory state of pro-inflammatory M1 












Materials and Methods 
 
Cell lines  
The RAW 264.7 murine macrophage cell line (ATCC TIB-71) is an Abelson murine 
leukemia virus-induced tumor, adherent macrophage cell line produced from a male 
BABL/c mouse. RAW 264.7 cells were grown in either 25 cm2 or 75cm2 vented cap cell 
culture flasks and incubated at 5% CO2 with a temperature of 37°C using a water-
jacketed incubator. Cells were cultured in media containing Dulbecco's Modified Eagle's 
Medium (DMEM) and 10% fetal bovine serum (FBS). Cells were cultured in vented cap 
flasks in a ratio of 1:5, upon reaching confluency of 70%.  
The Neuro-2a murine neuroblast cell line (ATCC-CCL-131) is an adherent 
neuroblastoma cell line produced in a strain A mouse. Neuro-2a cells were grown in an 
environment of 5% CO2 and a temperature of 37°C using a water-jacketed incubator. 
Cells were cultured in either 25 cm2 or 75cm2 vented cap growing flasks with media that 
contained DMEM and 5% FBS. Further passages were subcultured in vented cap flasks 
in a ratio of 1:5, upon reaching 70% confluency. Vented cap flasks, growth medium, and 
fetal bovine serum were purchased from Fisher Scientific. 
 
Polarization Treatment 
RAW 264.7 macrophages were grown to approximately 70% confluency; cells were then 
removed from the growing flasks via a cell scraper and collected into 15 mL conical 
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tubes. Cells were centrifuged at 1700 revolutions per minute (4°C) for 5 minutes; 
supernatants were removed using a vacuum flask while the cell pellet was resuspended in 
1 mL of complete growth medium. Cells were then counted and aliquoted into 25cm2 
growing flasks with roughly 1.0 X 106 cells per flask. Cells were allowed to become 
adherent to the growing flasks when the appropriate polarization treatment was 
administered. RAW 264.7 macrophages achieved a M1 phenotype from treatment with 
20 ng/mL IFN-γ (biolegend) and 100 ng/mL LPS (Chondrex) for 18 hours. M2 
phenotype was obtained by a treatment with 10 ng/mL IL-10 (Biolegend) for 18 hours. 
After the 18-hour treatment time cells were prepared for a phagocytosis assay. 
 
Cell Viability and Cell Counting 
RAW 264.7 macrophages were aliquoted into 24-well plates at a seeding density of 
0.1X106 cells per well, cells were allowed to attach to the culture plates for two hours. 
After attachment to the cell culture plates the appropriate cytokines were added to 
achieve either M1 (LPS/IFN-γ) or M2 (IL-10) phenotype;  SOCS 1/3 protein mimetics 
were added at a concentration of 35uM. Untreated cells were used as a control; all 
treatments were for a period of 18 hours. After the treatment period cells were scraped 
from the bottom of the 12-well plate using a cell scraper and collected into 1.5 mL 
microcentrifuge tubes. The supernatant was aspirated off after centrifugation at 1700 
revolutions per minute (4°C) for a time limit of 5 minutes. The cell pellet was 
resuspended in 1 mL of complete growth medium and stained with trypan blue (Fisher 
Scientific) at a 2:1 ratio; cells were then placed on a hemocytometer to determine cell 
viability. Viable cells were translucent while the dead cells were stained blue when 
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examined using a phase contrast microscope. The following equation was used to 
determine cellular viability:  
% Cell Viability =
Total viable Cells (unstained)
Total Cells (viable and dead) ×100 
 
Immunofluorescent Staining  
Cells were grown in vented capped growing flasks to approximately 70% confluency; 
cells were then counted and 0.05X106 cells were seeded onto slide chambers (Fisher 
Scientific). Cells were incubated at 37°C for 24 hours. Following incubation medum was 
removed and cells were washed twice with 1X PBS; after washing cells were fixed with 
4% paraformaldehyde for 15 minutes at RT. Once cells were fixed to the slide chamber, 
cells were washed thrice with 1X PBS. For the staining of internalized proteins, cells 
were made permeable with 0.2% triton X100 for 10 minutes at RT. Next, cells were 
washed thrice with cold 1X PBS to remove permeabilization agent and nonspecific 
binding was blocked using a blocking solution containing 5% goat serum, 3% BSA, 0.5% 
tween20 in PBS for one hour at RT. Blocking solution was then removed and cells were 
washed thrice with 1% BSA solution, each subsequent wash step was done three times 
with 1% BSA. Next, cells were incubated with the respective primary antibodies for 1 
hour at 4° C, followed by washing. In the dark, cells were then incubated with the 
fluorescent secondary antibody for 2 hours at RT followed by washing. After the last 
washing all liquid was completely aspirated off, silicone chamber was removed and the 
slide was left for 10 minutes at RT and then several drops of VectaShield (Vector 
Laboratories) was added to preserve the stained cells. A glass cover slip was then placed 
on top of the VecatShield and allowed to harden at RT for 20 minutes. Slides were then 
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analyzed using an Olympus Epi Fluorescence microscope with a real time spot color 
camera. 
 
Table 1: Summary of Primary and Secondary Antibody Concentrations used to Confirm 
Cell Lines Used in the Current Study.  
Antibody Concentration Company 
Anti-CD11b (primary) 5	μg/mL Abcam 
Goat Anti-Rat IgG H&L 
conjugated to AlexaFluro 
488 (secondary) 
4	μg/mL Abcam 
Anti-MAP2 (primary) 5	μg/mL Abcam 
Goat Anti-Rabbit IgG H&L 
conjugated to AlexaFluor 
488 (secondary)  
4	μg/mL Abcam 
 
Optimization of Micro Particles 
In preliminary experiments FITC labeled micro particles (Sigma-Aldrich) were used to 
develop a phagocytosis assay. Micro particles were optimized for the recognition by 
RAW 264.7 macrophages by incubation with 5% normal mouse serum (Thermo-Fisher 
Scientific) in DMEM. Once particles were optimized they were placed onto polarized 
macrophages at a ratio of 2:1 (beads:macrophages).  
 
CFSE staining of Neuro-2a Cells 
Neuro-2a cells were harvested from growing flasks after they reached 70% confluency. 
Cells were counted using a hemocytometer and 3X106 cells were placed into 15 mL 
centrifuge tubes. Neuro-2a cells were resuspended in PBS and 0.5 μM of staining 
solution was added to the cell suspension and allowed to incubate at room temperature 
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(RT). Cells were then washed twice with 5% complete growth medium and incubated at 
37°C. All wash steps were spun at 1700 revolutions per minute for 5 minutes at 4°C. 
Once the cells were washed they were placed on top of polarized macrophages at a ratio 
of 2:1 (Neuro-2a cells:macrophages). 
 
Phagocytosis Assay  
Micro-particles, CFSE stained Neuro-2a, or Anti-CRT cells were placed on top of a 
polarized monolayer of macrophages at a ratio of 2:1 with fresh 10% growth medium. 
Cells underwent phagocytosis assay at 5% CO2 and a temperature of 37°C in a water-
jacketed incubator. After phagocytosis micro particles or stained cells were washed five 
times using 4°C PBS to stop the uptake of either the micro-particles or Neur-2a cells. 
Macrophages were then removed from growth flasks using cell scrapers and collected 
into 15 mL centrifuge tubes. Cells were then prepared for cell surface antigen staining of 
macrophages to be detected by flow cytometry. 
 
Flow Cytometry  
Cell Surface Antigen Staining  
Once the cells were collected after the phagocytosis they were washed once with 1% 
Bovine Serum Albumin (BSA). Following incubation and wash steps, cells were 
centrifuged at 1200 revolutions per minute for 5 minutes at 4 °C and the supernatants 
were removed. Cells were then blocked for nonspecific binding by incubation for 20 
minutes with 3% BSA at RT. Cells were then washed to remove any excess blocking 
solution with 1% BSA. Following the washing, cells were incubated at RT for 30 minutes 
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with F4/80 primary antibody conjugated with eFluor 660 (ebioscience). After incubation 
cells were washed with 1% BSA once and then resuspended in 4°C PBS and filtered 
through falcon tubes to be analyzed by flow cytometry on an Accuri C6 Flow Cytometer 
(BD Biosciences).  
Intracellular Staining  
Cells were grown to approximately 70% confluency, harvested from growth flasks using 
trypsin, and resuspened in 1X PBS. Cells were then counted using a hemocytometer and 
approximately 3.0X106 cells were added to 1.5 mL microcentrifuge tubes. Following 
incubation and wash steps, cells were centrifuged at 1200 revolutions per minute for 5 
minutes at 4 °C and the supernatants were removed. Cells were then fixed using fixation 
buffer (Biolegend) in the dark for 20 minutes at RT. Following fixation cells were 
washed twice using 1X intracellular staining perm wash buffer (Biolegend). Next, cells 
were stained for Calreticulin with Anti-CRT antibody conjugated with Alexa Fluro 488 
(abcam). Antibodies and cells were incubated at RT for 20 minutes followed by washing 
with 1X intracellular staining perm wash buffer. Finally, stained cells were resuspended 
with 4°C PBS and filtered through falcon tubes and to be analyzed by flow cytometry on 
an Accuri C6 Flow Cytometer (BD Biosciences) that recorded 50,000 events.   
Table 2: Summary of Primary Antibody and Isotype Control Concentrations used for 
Flow Cytometery Analysis in the Current Study.  
Antibody Concentration Company 
Anti-F4/80 conjugated to 
eFluro 660 
10 µg/mL ThermoFisher 
Rat IgG2a K Isotype 
Control conjugated to 
eFluro 660 
10 µg/mL ThermoFisher 
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Anti-Calreticulin 
conjugated to Alexa Fluro 
488 
10 µg/mL Abcam 
Rabbit IgG Isotype Conrol 
conjugated to Alexa Fluro 
488 
10 µg/mL Abcam 
 
Statistical Significance  
Statistical significance was determined using a One-Way ANOVA using SigmaPlot 12.0; 




F4/80 Receptor is a Universal Murine Macrophage Marker  
 RAW264.7 murine macrophages were treated with various cytokines to promote 
phenotypic changes: IFN-γ and LPS to achieve M1 phenotype, IL-1-0 to reach M2 
phenotype and untreated control macrophages (M0).  Macrophages were then stained for 
the murine cell surface receptor F4/80 and isotype controls to calculate the positive 
differences in binding efficiency. M2 and M0 macrophages showed the highest difference 
in binding, with M1 macrophages showing a slight decrease (Fig. 3). These results allow 
the use of F4/80 as a common murine macrophage marker. 
 
M1 Polarized Macrophages are More Efficient at Clearing Foreign Materials  
 Following 18 hour cytokine treatment for M1 (IFN-γ/ LPS) and M2 (IL-10) 
polarization, M1 macrophages phagocytized more FITC latex beads compared to control 
M0 and M2 macrophages, while M2 macrophages exhibited similar amounts of 
phagocytosis compared to control M0 macrophages. (Fig. 4, Fig. 5). Similarly, when N2a 
cells stained with CFSE were co-cultured with macrophages, M1 macrophages 
phagocytized more N2a cells and M0 and M2 macrophages phagocytized similar 
amounts (Fig. 6, Fig. 7). 
 
Phagocytosis of N2a Cells is Decreased When Prominent “Eat Me” Signal is Blocked  
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When calreticulin is blocked on N2a cells the amount of overall phagocytosis was 
decreased significantly in control, M1, and M2 macrophages (Fig. 13, Fig. 14, Fig. 15). 
M1 macrophages still phagocytized a greater amount then either control and M2 
macrophages. M2 and M0 control macrophages phagocytized similar amounts of N2a 
cells that had their “eat me” signal blocked. Continuing the understanding that 
calreticulin is a major signal that is involved in tumor clearance.  
 
SOCS1 Peptide Mimetic has a Positive Affect on Phagocytosis Ability of M1 
Macrophages  
SOCS1 peptide mimetic increases the amount of phagocytosis of CFSE labeled 
N2a cells when compared to M1 macrophages without SOCS peptide mimetic treatment 
(Fig. 7B Fig. 9, Fig. 11). When SOCS1 peptide mimetic was added to control M0 
macrophages and M2 macrophages the amount of phagocytosis of CFSE labeled N2a 
cells was not increased (Fig. 8, Fig. 10, Fig. 11). M1 macrophages that were treated with 
SOCS1 peptide mimetic also had the ability to increase phagocytosis of N2a cells that 
had their “eat me” signals blocked (Fig. 17). Again SOCS1 peptide mimetic had no effect 
on the phagocytic ability of M0 or M2 macrophages when targets had their “eat me” 
signals blocked (Fig. 16, Fig. 17).  
 
SOCS3 Peptide Mimetic Increases Phagocytosis of Early Apoptotic N2a Cells by M2 
Macrophages.  
M2 and M0 control macrophages were treated with SOCS3 peptide mimetic and 
co-cultured with anti-CRT N2a cells; phagocytosis was increased compared to no SOCS 
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peptide mimetic treatment (Fig. 16, Fig.18). M1 macrophages treated with SOCS3 
peptide showed a slight increase compared to macrophages that were treated with no 












































































































































































Figure 5: Flow cytometry data, represented as quadrant graphs, of the phagocytosis of 
latex beads by RAW264.7 macrophages. Percentage of phagocytosis is found in the 
upper right quadrant. M1 (B) polarized macrophages show a greater ability to 
phagocytose latex beads compared to both M0 (A) and M2 (C), while M2 and M0 
show a similar pattern of phagocytosis. Quadrants were drawn with respect to 
unstained unpolarized macrophages (D). Experiments were completed in triplicates 















































































































































































































































































phagocytose	Neuro-2a	(N2a)	cells. M1 polarized macrophages (B) were able to 
phagocytose labeled N2a cells more successfully then both M0 (A) and M2 (C), these 
results were statistically significant. M0 and M2 were not different in their ability to 
phagocytose the labeled N2a cells. Quadrants were drawn with respect to unstained 
unpolarized macrophages (D). Experiments were completed in triplicates with one 


















































































































not	statistically	significant.	Quadrants were drawn with respect to unstained 
unpolarized macrophages (D). Experiments were completed in triplicates with one 





























































































significant	compared	to	M2	macrophages.	Quadrants were drawn with respect to 
unstained unpolarized macrophages (D). Experiments were completed in triplicates 














































Figure 13: Phagocytosis of Anti-CRT Neuro-2a (N2a) cell by RAW264.7 
macrophages. M1 polarized macrophages were able to phagocytose more N2a cells 
compared to both M0 and M2 macrophages. Also, there was no statistical difference 




























































































to	M0	but	it	was	not	statistically	significant.	Quadrants were drawn with respect to 
unstained unpolarized macrophages (D). Experiments were completed in triplicates 




Figure 15: Anti-CRT affects the ability of RAW264.7 macrophages to phagocytize 
Neuro-2a (N2a) cells. N2a cells treated with anti-CRT decrease the amount of 
phagocytosis by RAW264.7 macrophages, leading to a greater survival rate of N2a 
cells. All three phenotypes (M0, M1, & M2) of macrophages showed a decrease in 








































Figure 16: Effects of SOCS peptide mimetics on phagocytosis of Nuero-2a (N2a) 
cells stained with either CFSE or anti-CRT by unpolarized RAW264.7 macrophages. 
N2a cells blocked with anti-CRT showed a decrease in phagocytosis when treated 
with SOCS 1 peptide mimetic and with no SOCS peptide mimetic treatment. 















































Figure 17: Effects of SOCS peptide mimetics on phagocytosis of Neuro-2a (N2a) 
cells stained with either CFSE or anti-CRT by M1 polarized RAW264.7 macrophages.  
M1 polarized macrophages, with SOCS1 peptide mimetic and without, showed a 
decrease in phagocytosis of anti-CRT N2a cells. Treatment with SOCS3 peptide 

















































Figure 18: Effects of SOCS peptide mimetics on phagocytosis of Neuro-2a (N2a) 
cells stained with either CFSE or anti-CRT by M2 polarized RAW264.7 macrophages. 
M2 polarized macrophages, with SOCS1 peptide mimetic treatment and without, 
showed a decrease ability to phagocytize N2a cells with anti-CRT treatment. SOCS3 























































































































































phagocytosis	but	it	was	not	significantly	significant.		Quadrants were drawn with 
respect to unstained unpolarized macrophages (D). Experiments were completed in 


















































































Figure 20: Quadrant Graphs representing effects of SOCS3 peptide mimetic on 
phagocytosis of anti-CRT Neuro-2a (N2a) cells by RAW264.7 macrophages. M0 
macrophages (A) and M2 polarized macrophages (C) showed an increase amount of 
phagocytosis when treated with SOCS3 peptide mimetic. By contrast M1 polarized 
macrophages (B) show a decreased amount of phagocytosis compared to both M0 and 
M2 macrophages when treated with SOCS3 peptide mimetics.  
Quadrants were drawn with respect to unstained unpolarized macrophages (D). 





This study was focused on determining whether treatment of pro-inflammatory 
M1 RAW264.7 macrophages with SOCS3 peptide mimetic resulted in an anti-
inflammatory phenotype leading to a decreased phagocytosis of malignant cells while 
treatment of anti-inflammatory M2 macrophages with SOCS1 peptide mimetic increased 
phagocytosis. Blocking the “eat me” signal of the Neuro-2a target cells should decrease 
phagocytosis by the RAW264.7 macrophages. 
When CFSE labeled N2a cells were added to polarized macrophages, pro-
inflammatory M1 macrophages showed a significant increase in the percentage of 
phagocytosed malignant cells, whereas M0 and M2 macrophages did not differ in their 
ability to phagocytose the target malignant cells. These results suggest that M1 
macrophages play a key role in the clearance of the malignant cells, while M2 
macrophages act more closely to control M0 macrophages in the clearance of viable cells. 
When calreticulin “eat me” signaling was blocked with anti-CRT in each of the three 
macrophage phenotypes, significant decreases in phagocytosis occurred while  M1 
macrophages phagocytized significantly higher percentages of target cells than did M0 or 
M2 macrophages. This observation demonstrates that CRT is a prominent “eat me” signal 
present on N2a cells.  
SOCS1 or SOCS3 peptide mimetic were added to adherent RAW264.7 
macrophages polarized to either the pro-inflammatory M1 or anti-inflammatory M2 
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phenotype. At 18 hours after polarization, M1 treatment caused a significant decrease in 
cell viability compared to other treatment groups. The most likely explanation for the 
decrease in cell viability is that upon treatment with M1 polarizing substance, LPS and 
IFN-γ, M1 macrophages secrete nitric oxide (NO), which is toxic to cells (Seminara et 
al., 2007). It is worth noting that the addition of either SOCS1 or SOCS3 peptide mimetic 
did not negatively affect the viability of RAW264.7 macrophages. Control M0, M1, and 
M2 macrophages were all stained for the cell surface receptor F4/80 and analyzed by 
flow cytometry. All three subtypes of macrophages have equal expression of the F4/80 
receptor supporting its use as a macrophage marker in this study. 
While SOCS1 peptide mimetic significantly increased the percentage of 
malignant cells phagocytosed by M1 polarized macrophages, it did not enhance the 
percentage of target cells phagocytosed by M2 polarized macrophages. This observation 
indicates the addition of SOCS1 peptide mimetic may induce increased levels of 
receptors and cytokines involved in the phagocytic process but cannot cause a phenotypic 
switch from anti-inflammatory to pro-inflammatory behavior by M2 macrophages. These 
results were seen when target cells were stained with CFSE (unblocked) or anti-CRT. 
When LPS is used as a polarization agent in macrophages cellular SOCS1 expression is 
increased, so with the addition of the SOCS1 peptide mimetic will cause an over 
expression of the SOCS1 protein (Nakagawa et al., 2002). This over expression enhances 
the phagocytic potential of M1 macrophages permitting them to clear significantly more 
target cells.  
SOCS3 peptide mimetic had a positive affect on the phagocytic ability of M2 
polarized macrophages when target cells were treated with anti-CRT.  One explanation 
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for this observation is that this increase in phagocytosis occurs because blocking of CRT, 
an endoplasmic reticulum protein, involves disrupting the cell membrane. This disruption 
in the cell membrane will cause cells to express the apoptotic signal PS which M2c cells 
recognize and phagocytose. Another possible explanation is that M2 macrophages 
polarized with IL-10 have an increased amount of the tumor associated macrophage 
(TAM) receptor merTK, an intracellular negative feedback regulator that inhibits the 
macrophage inflammatory response and functions in the clearance of apoptotic cells 
(Zizzo et al. 2012).  Graham et al. 2006 suggest that the high levels of merTK expressed 
on tumor infiltrating macrophages may increase their efficiency at clearing apoptotic 
melanoma cells.  The addition of SOCS3 peptide mimetic to the macrophages could have 
increased their expression of merTK resulting in the increased phagocytosis since merTK 
expression is activated along with SOCS3 expression (Zhang et al., 2016). 
Overall the present study shows the importance of macrophage phenotype in 
cytokine signaling as it pertains to clearance of malignancy. Taken together the current 
results suggest a potential pathway for using SOCS peptide mimetics to increase 
phagocytosis of malignant cells by murine macrophages in a phenotypic specific manner. 
M1 polarized cells treated along with SOCS1 peptide mimetic significantly increased the 
phagocytosis of target cells by manipulating the release of cytokines. Interestingly, the 
addition of SOCS3 peptide mimetic to macrophages polarized to the M2c phenotype 
showed a remarkably significant increase in the percentage of phagocytosis of target cells 
with their “eat me” signal blocked. One potential explanation for this occurrence is that 





Based on the present study, there are many opportunities for future studies using 
the current protocols. The current study utilized a Neuro-2a cell line as a target cell and 
RAW264.7 murine macrophages as phagocytes. Logically the next step would be to 
compare the current results with the phagocytic ability of J774A.1 murine macrophages. 
It would be beneficial to expand the study to include a primary human macrophage as 
well to compare phagocytosis across species. Another avenue to explore would be to use 
different target cells. Other malignancies that have been shown to express high levels 
CRT include breast, brain, and bladder cancer.  
This study used macrophages that were polarized using Il-10 to the M2c 
phenotype; they are known for apoptotic cell clearance. M2c macrophages along with 
SOCS3 peptide mimetic treatment resulted in a significant increase in the clearance of 
target cells that had CRT blocked. To gain a better understanding of the spectrum of the 
M2 phenotype, polarization treatments of IL-4 and IL-13 should be used to analyze their 
phagocytic ability. Along with examining the other phenotypes the expression of the 
TAM merTK receptor should be studied because it has been linked to have an increased 
expression in Il-10 stimulated macrophages. These macrophages are known for their 
clearance of cells that express apoptotic signals on the cell surface. Since M2c 
macrophages are known for clearing apoptotic cells, target cells with CRT blocked need 
to be studied to see if they have an increased expression of these signals.  
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SOCS proteins’ major role in the immune system is to regulate the production an 
release of cytokines into the cellular microenvironment by immune cells. The cytokines 
that are released or inhibited will control how the immune cell and surrounding cells react 
to foreign materials. The present study shows a significant increase in the phagocytic 
ability of M1 macrophages treated with SOCS1 peptide mimetic. Since TNF-α, a 
polarizing M1 cytokine, functions in an autocrine manner the supernatant fluids of cells 
from this experiment should be analyzed for TNF- α. The continued production of TNF- 
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